World Health Organization: Evidence of Illness, Not Required for Reporting
The World Health Organization has stated, with bureaucratic clarity, that evidence of illness is not required to trigger mandatory international reporting of a laboratory-confirmed human influenza infection that carries pandemic potential. The phrase appears in its latest assessment of influenza at the human-animal interface: countries must notify WHO immediately of any such laboratory-confirmed case. Then comes the quiet rider: "Evidence of illness is not required for this report." The determination rests not on fever, cough, hospitalisation, or death, but on a laboratory result. That result, in turn, is produced by real-time RT-PCR, a method that does not observe a virus directly. It measures fluorescence emitted by chemical reagents mixed with a sample after repeated cycles of heating. Fluorescence can rise for reasons unrelated to the presence of a pathogen: reagent cross-reactions, probe degradation, optical interference, or the simple thermal stress the machine itself applies. WHO's own laboratory manuals acknowledge background signal, contamination, and the possibility of false-positive readings.
When the gateway to a pandemic declaration no longer requires a single person to be sick, the system is structurally primed to generate alerts that float free of clinical reality. A fluorescent signal in a tube becomes the functional equivalent of disease. Once reported, that signal enters the machinery of international surveillance. Officials, media, and pharmaceutical contractors respond as though a genuine threat has been detected. Stockpiles are reviewed, research contracts accelerate, and the language of preparedness expands. The economic incentives align neatly with the technical threshold. Vaccine platforms, diagnostic kits, antiviral contracts, and global coordination frameworks all depend on a steady supply of potential crises. A system that can declare pandemic potential without illness is a system that can keep the pipeline of urgency permanently open.
The experience of COVID-19 demonstrated how rapidly such declarations translate into policy. Lockdowns, travel bans, school closures, and vaccination requirements followed the formal recognition of a public-health emergency. Those measures generated enormous revenue for pharmaceutical manufacturers while imposing lasting social and economic costs. If future determinations can be triggered by laboratory signals alone, the same cycle becomes easier to restart. False or exaggerated alerts do not need to be malicious inventions; they need only to pass through a detection method known to produce artifacts. Each artifact can be treated as actionable data. Each actionable data point sustains the institutional and commercial apparatus built around pandemic response.
The result is a feedback loop that rewards the detection of signals over the demonstration of widespread illness. Public-health bureaucracies remain relevant. Research budgets remain justified. Manufacturers retain a market for products whose demand spikes whenever a new threat is named. The absence of clinical evidence does not interrupt the process; it simply removes one of the traditional brakes. In this arrangement, the system stays in business not despite the possibility of false declarations, but partly because of it. The fluorescence rises, the report is filed, and the machinery of response turns once more, keeping the profits flowing while the distinction between laboratory artifact and genuine pandemic grows ever thinner.
https://jonfleetwood.substack.com/p/who-says-pandemic-determinations
